Originally Posted by
psychic
Balance and Skid.
If you guys are going to spend so much of your life bashing this stock and saving the rest of us, then please put some effort in understanding it eh?
Look, there is no AUA report. The AUA put some questions up to the AHRQ to review data about BCa urinary biomarkers amongst other things. Chow et al then reviewed available Pubmed evidence and came up with a summary. They concluded that OVERALL, Urinary biomarkers missed a significant number of tumours. (They do, mostly TA , Tis - low grade cancers that won't kill) . CxBladder detect rated better than the other tests but with only one study published, the strength of evidence was considered too low to lift the very average performance of the other tests.
I actually sent you a copy of this AHRQ draft some 18 months ago skid.
So, firstly. There has not been an independent AUA report, you gurus and legends are getting excited about the same thing. Secondly, this is a summary only of the data published on pubmed. Okay? You understand they have not gone out and independently tested anything right?
Thirdly, the performance of CxBladder Detect, although better than the other biomarkers, has not been weighted in because there was only the one study published.
Four. The market for Urinary Biomarkers is already huge- and a summary document by AHRQ will not change that.
Last. This "report" does not consider CxBladder Triage AT ALL.
And you need to understand Triage and the space it has if you really are going to follow PEB.